GlobeNewswire•26 days agoTScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme MalignanciesTCRX2.54%
GlobeNewswire•Jun 25, 2026Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and CanadaCOSM6.73%